Mastopexy Market: Current Analysis and Forecast (2025-2033)

Emphasis on Technique (Anchor Breast Lift, Crescent Breast Lifting, Benelli-Lollipop Lift, and Others); End-user (Hospitals, Specialty Clinics, and Others); and Region/Country

Geography:

Global

Industry:

Healthcare

Last updated:

May 2025

Global Mastopexy Market Size & Forecast

Global Mastopexy Market Size & Forecast

The global mastopexy market was valued at USD 625.9 million in 2024 and is expected to grow to a strong CAGR of around 7.2% during the forecast period (2025-2033F), owing to the increasing demand for aesthetic enhancement procedures due to rising body image consciousness, advancements in surgical techniques, and safer, less invasive procedures.

Mastopexy Market Analysis

Mastopexy is also referred to as breast lift surgery. It aims to raise and restructure the sagging breasts. This type of breast surgery is popular amongst those who feel they have sagging breasts, due to factors such as aging, weight, pregnancy, or heredity. A breast lift does not require implants or a breast reduction, but can be performed in combination with breast implants, depending on the patient's desired outcome. The availability of less invasive surgical procedures like the Benelli-lollipop lift and crescent lift increases their popularity among the population due to their shorter recovery periods. Additionally, social media influence, along with people’s interest in natural-looking aesthetics, has further increased the demand.

Global Mastopexy Market Trends

This section discusses the key market trends that are influencing the various segments of the global mastopexy market, as found by our team of research experts.

Combination Procedures

Combination procedures mean the two procedures are increasingly being used together in the mastopexy market, where breast lift is usually done concurrently with breast augmentation or fat grafts. It also offers the added benefit of achieving both breast enhancement in terms of shape and size, and requires fewer surgeries, thus improving the patient’s healing time and reducing cost. This is why patients are now demanding individualized and time-effective operations, which are easily offered by combined surgeries. Moreover, surgeons are also recommending these options because these surgeries give better aesthetics and long-term satisfaction, thereby making the combination surgery a strategic addition to the aesthetic market.

Mastopexy Industry Segmentation

This section provides an analysis of the key trends in each segment of the global mastopexy market report, along with forecasts at the global, regional, and country levels for 2025-2033.

Anchor Breast Lift Technique Dominates the Mastopexy Market.

Based on technique, the market is divided into anchor breast lift, crescent breast lift, benelli-lollipop lift, and others. Among these, the anchor breast lift segment dominates the mastopexy market due to the efficiency of the procedure for treating severe breast droopiness and providing patients with highly satisfying long-term results. Due to its capability of handling complicated matters, its demand has remained high despite the emergence of other techniques. However, the Benelli-Lollipop Lift segment is considered to grow at the fastest pace in the future. This technique is less invasive and delivers efficient lifting, which makes it appealing to patients searching for an aesthetic solution with limited scarring.

Hospitals Segment Dominates the Mastopexy Market.

Based on the end-user category, the global market is categorized into hospitals, specialty clinics, and others. Of all these categories, hospitals currently hold the maximum market share in the global mastopexy market because they possess well-equipped procedural facilities, experienced plastic surgeons, and extensive follow-up care services. However, the specialty clinics segment is likely to experience a steadier growth rate than the other segments in the future. Specialty clinics have some advantages, such as personalized care, shorter waiting times compared to a hospital, cheaper prices, and a comfortable, patient-focused environment that is attracting more patients seeking elective surgery, such as cosmetic surgeries.

Global Mastopexy Market Segments

The North America region holds a significant market share in the Global Mastopexy Market.

The North American region is expected to dominate the global mastopexy market because of factors such as the favourable economic status, culture, and healthcare facilities in the region. It is estimated that the countries from North America, specifically the United States, have one of the highest numbers of cosmetic surgeries globally due to the culture that supports looks, health, and self-esteem. The presence of board-certified and highly qualified plastic surgeons to provide quality services and great results, increased demand for aesthetic surgeries such as mastopexy. Moreover, North America has an effective and superior healthcare system coupled with better surgical practices, and better acceptance and accessibility of innovative technology or advanced surgeries, leading to its dominance.

The U.S. held a Dominant share of the North American Mastopexy Market in 2024

The United States holds the largest market share for mastopexy in North America because of the advanced healthcare system, increased healthcare expenditure for aesthetic procedures, and cultural approval for cosmetic surgery in the country. It is in the top list of countries that undertake cosmetic surgeries such as mastopexy, due to enhanced awareness and demand for body modification. A high number of board-certified plastic surgeons and abundant clinics with modern equipment provide high chances of positive results and satisfied patients, resulting in increased demand for mastopexy. Moreover, the increased use of social networks, endorsement of celebrities, and the change in the definition of beauty have paved the way for breast augmentation across different age brackets. Additionally, the U.S. continues to demonstrate advancements and innovation in the healthcare system, enabling quick expansion of minimally invasive and combination procedures for the increasing customer-centric market need.

Global Mastopexy Market Trends

Mastopexy Industry Competitive Landscape

The global mastopexy market is competitive, with several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, geographical expansions, and mergers and acquisitions.

Top Mastopexy Companies

Some of the major players in the market are HCA Healthcare Inc., VCU Health System, Mount Sinai, UCLA Health, Cedars-Sinai, NYU Langone Health, Pristyn Care, Enhance Medical Group, Eterna Vision and Aesthetics, and Kirn Plastic Surgery and Skincare Center.

Recent Developments in the Mastopexy Market

  • In December 2024 – Mentor Worldwide LLC announced that the U.S. Food and Drug Administration (FDA) had approved MENTOR™ MemoryGel™ Enhance Breast Implants for primary and revision breast reconstruction surgery in women following mastectomy. Mentor plans to officially launch the MemoryGel™ Enhance Breast Implants commercially in the U.S. starting in mid-2025. These implants are expected to be used extensively in breast lifting surgery.

  • In June 2023 – Sientra, Inc. announced that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for its novel, patented AlloX2 Pro Tissue Expander. This breakthrough innovation enables the AlloX2 Pro to be labeled as MRI-conditional, making it the first tissue expander in the United States approved for use in patients undergoing magnetic resonance imaging, an essential screening tool for breast reconstruction.

Global Mastopexy Market Report Coverage

Report Attribute

Details

Base year

2024

Forecast period

2025-2033

Growth momentum 

Accelerate at a CAGR of 7.2%

Market size 2024

USD 625.9 Million

Regional analysis

North America, Europe, APAC, Rest of the World

Major contributing region

Asia-Pacific is expected to dominate the market during the forecast period.

Key countries covered

U.S., Canada, Germany, U.K., Spain, Italy, France, China, Japan, and India

Companies profiles

HCA Healthcare Inc., VCU Health System, Mount Sinai, UCLA Health, Cedars-Sinai, NYU Langone Health, Pristyn Care, Enhance Medical Group, Eterna Vision and Aesthetics, and Kirn Plastic Surgery and Skincare Center.

Report Scope

Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Demand and Supply Side Analysis; Competitive Landscape; Company Profiling

Segments Covered

By Technique, By End-user, By Region/Country

Reasons to Buy Mastopexy Market Report:

  • The study includes market sizing and forecasting analysis confirmed by authenticated key industry experts.

  • The report briefly reviews overall industry performance at a glance.

  • The report covers an in-depth analysis of prominent industry peers, primarily focusing on key business financials, type portfolios, expansion strategies, and recent developments.

  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

  • The study comprehensively covers the market across different segments.

  • Deep dive regional level analysis of the industry.

Customization Options:

The global Mastopexy market can further be customized as per the requirements or any other market segment. Besides this, UnivDatos understands that you may have your own business needs; hence, feel free to contact us to get a report that completely suits your requirements.

Table of Contents

Research Methodology for the Global Mastopexy Market Analysis (2023-2033)

We analyzed the historical market, estimated the current market, and forecasted the future market of the global mastopexy market to assess its application in major regions worldwide. We conducted exhaustive secondary research to gather historical market data and estimate the current market size. To validate these insights, we carefully reviewed numerous findings and assumptions. Additionally, we conducted in-depth primary interviews with industry experts across the mastopexy value chain. After validating market figures through these interviews, we used both top-down and bottom-up approaches to forecast the overall market size. We then employed market breakdown and data triangulation methods to estimate and analyze the market size of industry segments and sub-segments.

Market Engineering

We employed the data triangulation technique to finalize the overall market estimation and derive precise statistical numbers for each segment and sub-segment of the global mastopexy market. We split the data into several segments and sub-segments by analyzing various parameters and trends, including technique, end-user, and regions within the global mastopexy market.

The Main Objective of the Global Mastopexy Market Study

The study identifies current and future trends in the global mastopexy market, providing strategic insights for investors. It highlights regional market attractiveness, enabling industry participants to tap into untapped markets and gain a first-mover advantage. Other quantitative goals of the studies include:

  • Market Size Analysis: Assess the current and forecast market size of the global mastopexy market and its segments in terms of value (USD).
  • Mastopexy Market Segmentation: Segments in the study include areas of technique, end-user, and region.
  • Regulatory Framework & Value Chain Analysis: Examine the regulatory framework, value chain, customer behavior, and competitive landscape of the mastopexy industry.
  • Regional Analysis: Conduct a detailed regional analysis for key areas such as Asia Pacific, Europe, North America, and the Rest of the World.
  • Company Profiles & Growth Strategies: Company profiles of the mastopexy market and the growth strategies adopted by the market players to sustain in the fast-growing market.

Frequently Asked Questions FAQs

Q1: What is the global mastopexy market’s current market size and growth potential?

Q2: Which segment has the largest share of the global mastopexy market by technique category?

Q3: What are the driving factors for the growth of the global mastopexy market?

Q4: What are the emerging technologies and trends in the global mastopexy market?

Q5: What are the key challenges in the global mastopexy market?

Q6: Which region dominates the global mastopexy market?

Q7: Who are the key companies in the global mastopexy market?

Q8: What are the key opportunities for businesses and investors in the global mastopexy market?

Q9: How is technological advancement influencing the future growth of the mastopexy market?

Related Reports

Customers who bought this item also bought

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Private Health Insurance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Age Group (Senior Citizens, Adults, and Minors); Distribution channel (Direct Sales, Brokers/Agents, Banks, and Others); and Region/Country

June 20, 2024

India Catheter Market: Current Analysis and Forecast (2024-2032)

India Catheter Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Cardiovascular Catheters, Urology Catheters, Intravenous Catheters, Neurovascular Catheters, and Specialty Catheters); Material Type (Silicone, Polyurethane, Latex, and Others); Region

November 4, 2024

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Blood Pressure Cuffs Market: Current Analysis and Forecast (2024-2032)

Emphasis on Product Type (Manual, Automated), Usage Type (Reusable, Disposable), End-user (Hospitals, Home and Others); and Region/Country

October 16, 2024

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Antibiotic Resistance Market: Current Analysis and Forecast (2024-2032)

Emphasis on Disease Type (Urinary Tract Infections, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, And Others); Pathogen Type (Acinetobacter baumannii, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae, and Others); Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, and Others); and Region/Country

October 8, 2024